Pharmacogenomics
Pharmacogenomics in the Future of Health Care PracticeAbstract: Pharmacogenomics is an up and coming technology that encompasses the areas of health care, science, drug therapy and genetics. Pharmacogenomics research examines gene expression, and how drugs can be best suited to work with an individual's DNA sequence. Some drug therapies have already been developed by means of this research, but the effect of the use of pharmacogenomics in health care is slow to be seen. All health care professionals will be affected when the advancements of pharmacogenomics are in widespread use, and need to be prepared for its introduction. There are distinct sides to the controversial issue of pharmacogenomics in our society, and all individuals involved should be aware of the aspects of this new technology.Pharmacogenomics in the Future of Health CareThe study of genetics has brought about a new way of thinking to the world of science. But the field of science is not the only area affected by the advancements in genetics; it affects every aspect of humanity. The use of genetics lies in a gray area, where right and wrong is not easily decided. Separate communities of thinkers debate whether the use of genetics in science and technolo
Pharmacogenomics is a complicated issue when it comes to privacy, because personal and family information may be uncovered, and privacy would then include not only the patient, but others involved in the case. Supporters also defend pharmacogenomic research by affirming it as the only alternate form of developing and prescribing prescriptions that we are aware of at this time (Barash, 2001). Supporters of pharmacogenomics may present a good case regarding the need for research to help avoid unnecessary deaths and treatments and to prepare the world for the future, but some are not convinced. In a 2000 study conducted by the National Health Council (NHC), the focus group was divided, with just over a half stating that they would be willing to participate in a clinical study (Rothstein, 2003). There are concerns of unfairness with regards to health status, including denial of insurance and discrimination in the work environment among others (Rothstein, 2003). Pharmacogenomics is an important tool in health care and it needs to be used as such to give patients the best care current technology has to offer. Nurses must handle pharmacogenomic drug therapy as they would deal with other individualized ethical issues. Because this is the only alternate method of developing new drugs, it is thought that this method be explored, so that society is fully prepared for medical situations that will arise in the future. It encompasses both clinical response as well as adverse side effects and other physiological changes and can be applied to drugs in development as well as those in current use. Pharmacogenomics is one of these technologies and health care professionals need to be prepared for its impacts in the field. There are varying positions regarding the study of pharmacogenomics. The introduction of genetics into the health care field forces society to decide what is ethical in the use of these findings. These recent advancements have shown that more precise treatments can be available to patients if pharamacogenomic research continues and its findings are executed in future health care practice.
Common topics in this essay:
Rothstein Rothstein,
Gauchier Disease,
Pharmacogenomics ISP,
Abstract Pharmacogenomics,
Health Care,
Council NHC,
Genome Program,
health care,
drug therapy,
care professionals,
health care professionals,
barash 2001,
rothstein 2003,
future health,
future health care,
adverse drug reactions,
adverse drug,
gene expression,
pharmacogenomics research,
drug reactions,
Future Health,
International Society,
method developing drugs,
health care field,
Society Pharmacogenomics,
|
Acceptance Essays
